AUB ScholarWorks

Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon

Show simple item record

dc.contributor.author Otrock Z.K.
dc.contributor.author Oghlakian G.O.
dc.contributor.author Salamoun M.M.
dc.contributor.author Haddad M.
dc.contributor.author Bizri A.R.N.
dc.contributor.editor
dc.date Oct-2004
dc.date.accessioned 2017-10-05T15:37:35Z
dc.date.available 2017-10-05T15:37:35Z
dc.date.issued 2004
dc.identifier 10.1086/502312
dc.identifier.isbn
dc.identifier.issn
dc.identifier.uri http://hdl.handle.net/10938/15806
dc.description.abstract OBJECTIVE: To determine the incidence of urinary tract infections (UTIs) following transrectal ultrasound guided needle biopsy of the prostate (TRUBP) and the bacteriology of these infections. DESIGN: Retrospective evaluation of the charts and records of all patients who underwent TRUBP between June 1, 2002, and August 31, 2003. SETTING: American University of Beirut Medical Center, a tertiary-care center in Lebanon. PATIENTS: Two hundred seven patients underwent TRUER All received prophylactic antibiotics. One hundred twenty (58percent) received ciprofloxacin alone, whereas 87 (42percent) received both ciprofloxacin and gentamicin. Sixty-one patients (29.5percent) had an enema prior to the procedure, whereas 146 (70.5percent) did not. RESULTS: Thirteen patients (6.3percent) were admitted with UTI. All had rigors and fever on admission. Symptoms appeared at a mean of 2.7 days and the mean hospital stay was 9.2 days. The mean duration of antibiotic treatment was 23.2 days. Ten (77percent) of the patients had positive bacteriology. Urine cultures were positive in 8 (61.5percent) of the patients and blood cultures in 6 (46.2percent). All positive cultures grew Escherichia coli resistant to ciprofloxacin, with 5 isolates producing extended-spectrum beta-lactamases. CONCLUSIONS: TRUBP continues to be associated with significant infectious complications, especially UTI. Given the increasing incidence of antibiotic resistance mainly among the Enterobacteriaceae, antimicrobial prophylaxis practices should be reevaluated and the universal administration of quinolones alone or in combination with aminoglycosides should be reconsidered.
dc.format.extent
dc.format.extent Pages: (873-877)
dc.language English
dc.publisher THOROFARE
dc.relation.ispartof Publication Name: Infection Control and Hospital Epidemiology; Publication Year: 2004; Volume: 25; no. 10; Pages: (873-877);
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon
dc.type Article
dc.contributor.affiliation Otrock, Z.K., Department of Internal Medicine, Amer. Univ. of Beirut Medical Center, Beirut, Lebanon
dc.contributor.affiliation Oghlakian, G.O., Department of Internal Medicine, Amer. Univ. of Beirut Medical Center, Beirut, Lebanon
dc.contributor.affiliation Salamoun, M.M., Department of Internal Medicine, Amer. Univ. of Beirut Medical Center, Beirut, Lebanon
dc.contributor.affiliation Haddad, M., Department of Diagnostic Radiology, Amer. Univ. of Beirut Medical Center, Beirut, Lebanon
dc.contributor.affiliation Bizri, A.R.N., Division of Infectious Diseases, Department of Internal Medicine, Amer. Univ. of Beirut Medical Center, Beirut, Lebanon
dc.contributor.authorAddress Bizri, A.R.N.; Division of Infectious Diseases, Department of Internal Medicine, Amer. Univ. of Beirut Medical Center, Beirut, Lebanon; email: ab00@aub.ed.lb
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine;
dc.contributor.authorDepartment Internal Medicine
dc.contributor.authorDivision
dc.contributor.authorEmail ab00@aub.ed.lb
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorInitials Otrock, ZK
dc.contributor.authorInitials Oghlakian, GO
dc.contributor.authorInitials Salamoun, MM
dc.contributor.authorInitials Haddad, M
dc.contributor.authorInitials Bizri, ARN
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Bizri, ARN (reprint author), Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Infect Dis,Infect Control Committee Program, Beirut, Lebanon.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Araj G F, 2000, J Med Liban, V48, P221; Bizri A R, 2001, J Med Liban, V49, P257; BROWN RW, 1981, UROLOGY, V18, P145, DOI 10.1016-0090-4295(81)90425-8; Carey JM, 2001, J UROLOGY, V166, P82, DOI 10.1016-S0022-5347(05)66082-X; COPLEN DE, 1991, J UROLOGY, V146, P75; Daoud Z, 2003, Rev Esp Quimioter, V16, P233; Davis M, 2002, J UROLOGY, V167, P566, DOI 10.1016-S0022-5347(01)69087-6; Ghosn M, 1992, J Med Liban, V40, P4; Gilad J, 1999, J UROLOGY, V161, P222, DOI 10.1016-S0022-5347(01)62107-4; Griffiths K, 1998, BAILLIERE CLIN ENDOC, V12, P625, DOI 10.1016-S0950-351X(98)80008-6; Hall GE, 2002, AM J MED SCI, V324, P51, DOI 10.1097-00000441-200207000-00008; Hammond CJ, 2002, BRIT J NEUROSURG, V16, P550; Hamze Monzer, 2003, Sante, V13, P107; Kapoor DA, 1998, UROLOGY, V52, P552, DOI 10.1016-S0090-4295(98)00296-9; Naughton CK, 2000, J UROLOGY, V164, P388, DOI 10.1016-S0022-5347(05)67367-3; ROACH MB, 1991, UROLOGY, V38, P84, DOI 10.1016-0090-4295(91)80024-2; Rodriguez LV, 1998, J UROLOGY, V160, P2115, DOI 10.1016-S0022-5347(01)62255-9; Sanderson PJ, 2001, J CHEMOTHERAPY, V13, P89; Shandera KC, 1998, UROLOGY, V52, P644, DOI 10.1016-S0090-4295(98)00313-6; Sieber PR, 1997, J UROLOGY, V157, P2199, DOI 10.1016-S0022-5347(01)64716-5; Sturenburg E, 2003, J INFECTION, V47, P273, DOI 10.1016-S0163-4453(03)00096-3; Tal R, 2003, J UROLOGY, V169, P1762, DOI 10.1097-01.ju.0000061280.23447.29; Taylor HM, 1997, J ANTIMICROB CHEMOTH, V39, P115, DOI 10.1093-jac-39.2.115; VALLANCIEN G, 1991, J UROLOGY, V146, P1308
dc.description.citedCount 36
dc.description.citedTotWOSCount 33
dc.description.citedWOSCount 32
dc.format.extentCount 5
dc.identifier.articleNo
dc.identifier.coden ICEPE
dc.identifier.pubmedID 15518032
dc.identifier.scopusID 11144272114
dc.identifier.url
dc.publisher.address 6900 GROVE RD, THOROFARE, NJ 08086 USA
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr Infect. Control Hosp. Epidemiol.
dc.relation.ispartOfIssue 10
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle Infection Control and Hospital Epidemiology
dc.relation.ispartofPubTitleAbbr Infect. Control Hosp. Epidemiol.
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 25
dc.source.ID WOS:000224485700014
dc.type.publication Journal
dc.subject.otherAuthKeyword
dc.subject.otherChemCAS beta lactamase, 9073-60-3
dc.subject.otherChemCAS ciprofloxacin, 85721-33-1
dc.subject.otherChemCAS gentamicin, 1392-48-9, 1403-66-3, 1405-41-0
dc.subject.otherChemCAS Anti-Bacterial Agents
dc.subject.otherChemCAS Anti-Infective Agents
dc.subject.otherChemCAS Ciprofloxacin, 85721-33-1
dc.subject.otherChemCAS Gentamicins
dc.subject.otherIndex aminoglycoside antibiotic agent
dc.subject.otherIndex antibiotic agent
dc.subject.otherIndex beta lactamase
dc.subject.otherIndex ciprofloxacin
dc.subject.otherIndex gentamicin
dc.subject.otherIndex quinoline derived antiinfective agent
dc.subject.otherIndex antibiotic prophylaxis
dc.subject.otherIndex antibiotic resistance
dc.subject.otherIndex article
dc.subject.otherIndex bacterial infection
dc.subject.otherIndex blood culture
dc.subject.otherIndex Enterobacteriaceae
dc.subject.otherIndex Escherichia coli
dc.subject.otherIndex Gram negative infection
dc.subject.otherIndex hospital infection
dc.subject.otherIndex human
dc.subject.otherIndex incidence
dc.subject.otherIndex infection rate
dc.subject.otherIndex Lebanon
dc.subject.otherIndex major clinical study
dc.subject.otherIndex male
dc.subject.otherIndex nonhuman
dc.subject.otherIndex prostate biopsy
dc.subject.otherIndex prostate cancer
dc.subject.otherIndex retrospective study
dc.subject.otherIndex symptomatology
dc.subject.otherIndex transrectal ultrasonography
dc.subject.otherIndex university hospital
dc.subject.otherIndex urinary tract infection
dc.subject.otherIndex urine culture
dc.subject.otherIndex Anti-Bacterial Agents
dc.subject.otherIndex Anti-Infective Agents
dc.subject.otherIndex Biopsy, Needle
dc.subject.otherIndex Ciprofloxacin
dc.subject.otherIndex Drug Resistance, Bacterial
dc.subject.otherIndex Escherichia coli
dc.subject.otherIndex Escherichia coli Infections
dc.subject.otherIndex Gentamicins
dc.subject.otherIndex Humans
dc.subject.otherIndex Lebanon
dc.subject.otherIndex Length of Stay
dc.subject.otherIndex Male
dc.subject.otherIndex Prostate
dc.subject.otherIndex Retrospective Studies
dc.subject.otherIndex Urinary Tract Infections
dc.subject.otherKeywordPlus ANTIBIOTIC-PROPHYLAXIS
dc.subject.otherKeywordPlus PATIENT PREPARATION
dc.subject.otherKeywordPlus NEEDLE-BIOPSY
dc.subject.otherKeywordPlus CIPROFLOXACIN
dc.subject.otherKeywordPlus CANCER
dc.subject.otherKeywordPlus COMPLICATIONS
dc.subject.otherKeywordPlus BACTEREMIA
dc.subject.otherKeywordPlus FAILURE
dc.subject.otherKeywordPlus MEN
dc.subject.otherWOS Public, Environmental and Occupational Health
dc.subject.otherWOS Infectious Diseases


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account